Weight loss treatments and a life-saving breast cancer drug could be available to NHS patients under a new plan to stave off tariffs threatened by US President Donald Trump.

A proposal to counter Trump tariffs by raising the threshold used by England’s NHS spending watchdog by 25 per cent – therefore raising the amount the NHS pays pharmaceutical firms for drugs – has been briefed to Washington officials, according to reports.

The Government has confirmed it is in “advanced discussions” with the US to “secure the best outcome for the UK”. New Feature

In Short

Quick Stories. Same trusted journalism.

Experts have warned that the move would mean the health service pays more for medicines overall – and therefore could harm overall patient care.

But increasing the threshold would make it

See Full Page